PHARMA-BIO SERV, INC. Total Liabilities and Equity
PHARMA-BIO SERV, INC. (PBSV) had Total Liabilities and Equity of $11.44 million as of 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-09-14
- 2026-07-31: Liabilities and Equity $11.44M.
- 2026-04-30: Liabilities and Equity $11.50M.
- 2026-01-31: Liabilities and Equity $13.55M.
- 2025-10-31: Liabilities and Equity $13.65M.
| Period end | Liabilities and Equity |
|---|---|
| 2026-07-31 | $11.44M 10-Q · filed 2026-09-14 |
| 2026-04-30 | $11.50M 10-Q · filed 2026-06-15 |
| 2026-01-31 | $13.55M 10-Q · filed 2026-03-17 |
| 2025-10-31 | $13.65M 10-Q · filed 2026-09-14 |
| 2025-07-31 | $13.59M 10-Q · filed 2025-09-15 |
| 2025-04-30 | $13.90M 10-Q · filed 2025-06-16 |
| 2025-01-31 | $16.08M 10-Q · filed 2025-03-17 |
| 2024-10-31 | $16.29M 10-K · filed 2026-01-29 |
| 2024-07-31 | $16.32M 10-Q · filed 2024-09-16 |
| 2024-04-30 | $16.92M 10-Q · filed 2024-06-14 |
| 2024-01-31 | $19.23M 10-Q · filed 2024-03-18 |
| 2023-10-31 | $19.90M 10-K · filed 2025-01-29 |
| 2023-07-31 | $20.30M 10-Q · filed 2023-09-14 |
| 2023-04-30 | $19.62M 10-Q · filed 2023-06-14 |
| 2023-01-31 | $22.90M 10-Q · filed 2023-03-17 |
| 2022-10-31 | $20.65M 10-K · filed 2024-01-29 |
| 2022-07-31 | $20.33M 10-Q · filed 2022-09-14 |
| 2022-04-30 | $20.16M 10-Q · filed 2022-06-14 |
| 2022-01-31 | $22.07M 10-Q · filed 2022-03-17 |
| 2021-10-31 | $23.92M 10-K · filed 2023-01-30 |
| 2021-07-31 | $28.59M 10-Q · filed 2021-09-14 |
| 2021-04-30 | $27.90M 10-Q · filed 2021-06-14 |
| 2021-01-31 | $30.20M 10-Q · filed 2021-03-17 |
| 2020-10-31 | $29.92M 10-K · filed 2022-02-11 |
| 2020-07-31 | $30.10M 10-Q · filed 2020-09-14 |
| 2020-04-30 | $28.64M 10-Q · filed 2020-06-15 |
| 2020-01-31 | $26.16M 10-Q · filed 2020-03-16 |
| 2019-10-31 | $26.63M 10-K · filed 2021-02-01 |
| 2019-07-31 | $26.25M 10-Q · filed 2019-09-16 |
| 2019-04-30 | $25.65M 10-Q · filed 2019-06-14 |
| 2019-01-31 | $25.28M 10-Q · filed 2019-03-18 |
| 2018-10-31 | $25.38M 10-K · filed 2020-01-29 |
| 2018-07-31 | $23.31M 10-Q · filed 2018-09-14 |
| 2018-04-30 | $22.51M 10-Q · filed 2018-06-14 |
| 2018-01-31 | $22.41M 10-Q · filed 2018-03-19 |
| 2017-10-31 | $22.35M 10-K · filed 2019-01-29 |
| 2017-07-31 | $22.51M 10-Q · filed 2017-09-14 |
| 2017-04-30 | $22.56M 10-Q · filed 2017-06-14 |
| 2017-01-31 | $23.06M 10-Q · filed 2017-03-17 |
| 2016-10-31 | $24.00M 10-K · filed 2018-01-29 |
| 2016-07-31 | $24.02M 10-Q · filed 2016-09-14 |
| 2016-04-30 | $24.21M 10-Q · filed 2016-06-14 |
| 2016-01-31 | $23.84M 10-Q · filed 2016-03-16 |
| 2015-10-31 | $24.14M 10-K · filed 2017-01-31 |
| 2015-07-31 | $23.31M 10-Q · filed 2015-09-14 |
| 2015-04-30 | $23.09M 10-Q · filed 2015-06-15 |
| 2015-01-31 | $22.95M 10-Q · filed 2015-03-17 |
| 2014-10-31 | $23.21M 10-K · filed 2016-01-29 |
| 2014-07-31 | $22.03M 10-Q · filed 2014-09-15 |
| 2014-04-30 | $21.61M 10-Q · filed 2014-06-16 |
| 2014-01-31 | $21.08M 10-Q · filed 2014-03-17 |
| 2013-10-31 | $21.28M 10-K · filed 2015-01-29 |
| 2013-07-31 | $19.11M 10-Q · filed 2013-09-16 |
| 2013-04-30 | $18.03M 10-Q · filed 2013-06-14 |
| 2013-01-31 | $16.40M 10-Q · filed 2013-03-18 |
| 2012-10-31 | $15.74M 10-K · filed 2014-01-29 |
| 2012-07-31 | $13.92M 10-Q · filed 2012-09-14 |
| 2012-04-30 | $12.51M 10-Q · filed 2012-06-14 |
| 2012-01-31 | $11.47M 10-Q · filed 2012-03-16 |
| 2011-10-31 | $10.85M 10-K · filed 2013-01-29 |
| 2011-07-31 | $9.48M 10-Q · filed 2011-09-14 |
| 2010-10-31 | $6.56M 10-K/A · filed 2012-01-31 |